Schmidt T J, Meyer A S
Department of Physiology and Biophysics, University of Iowa, Iowa City 52242.
Receptor. 1994 Winter;4(4):229-57.
The corticosteroid receptors, including the glucocorticoid and mineralocorticoid receptors (GR and MR, respectively), are subject to ligand-mediated autoregulation like other members of the steroid receptor gene superfamily. Since it is the level of expression of these closely related intracellular receptors that determines cellular sensitivity to adrenal glucocorticoid and mineralocorticoid hormones, homologous as well as potential heterologous regulation of GR and MR levels constitute physiologically important homeostatic events. Although these autoregulatory responses are often exhibited in the form of receptor down-regulation (negative autoregulation), hormone-mediated up-regulation (positive autoregulation) has also been documented. Clearly, the extent as well as direction of hormone-mediated autoregulation of corticosteroid receptors vary considerably between different target tissues and cell types and may be altered during development or as a consequence of aging or disease state. Although historically the homologous as well as heterologous regulation of GR and MR were evaluated exclusively at the ligand binding levels, the cloning of the genes for these corticosteroid receptors has facilitated detailed analysis of hormonal regulation at the message and protein levels. Data generated in numerous laboratories have demonstrated that this regulation may be mediated at one or more molecular levels, including: the transcriptional level, as evidenced by the ability of ligand-receptor complexes to decrease the rate of receptor gene transcription; the posttranscriptional level, as evidenced by the ability of some ligands to alter the stability of their own receptor message; and at the posttranslational level, as evidenced by the ability of agonists to shorten the half-life of their own receptor protein. In this review we have focused on several basic questions (how, when, where, and why?) concerning this hormonal regulation of corticosteroid receptors. Clearly, many of these key questions concerning autoregulation of GR and MR levels remain unanswered and further studies in this area will enhance our understanding of the mechanisms involved in these cellular events.
皮质类固醇受体,包括糖皮质激素受体和盐皮质激素受体(分别为GR和MR),与类固醇受体基因超家族的其他成员一样,受配体介导的自身调节。由于这些密切相关的细胞内受体的表达水平决定了细胞对肾上腺糖皮质激素和盐皮质激素的敏感性,GR和MR水平的同源以及潜在的异源调节构成了生理上重要的稳态事件。尽管这些自身调节反应通常以受体下调(负向自身调节)的形式表现,但激素介导的上调(正向自身调节)也有文献记载。显然,皮质类固醇受体的激素介导的自身调节的程度和方向在不同的靶组织和细胞类型之间有很大差异,并且在发育过程中或由于衰老或疾病状态可能会发生改变。尽管历史上GR和MR的同源以及异源调节仅在配体结合水平进行评估,但这些皮质类固醇受体基因的克隆有助于在信息和蛋白质水平对激素调节进行详细分析。众多实验室产生的数据表明,这种调节可能在一个或多个分子水平上介导,包括:转录水平,配体-受体复合物降低受体基因转录速率的能力证明了这一点;转录后水平,一些配体改变其自身受体信息稳定性的能力证明了这一点;以及翻译后水平,激动剂缩短其自身受体蛋白半衰期的能力证明了这一点。在这篇综述中,我们重点关注了几个关于皮质类固醇受体激素调节的基本问题(如何、何时、何地以及为何?)。显然,许多关于GR和MR水平自身调节的关键问题仍未得到解答,该领域的进一步研究将增进我们对这些细胞事件所涉及机制的理解。